(716.2) Fibroblast Senescence: A Risk Factor for Remodeling, Inflammation, and Arrhythmias in the Post-MI Heart
Monday, April 4, 2022
10:15 AM – 12:15 PM
Location: Exhibit/Poster Hall A-B - Pennsylvania Convention Center
Poster Board Number: E108
Elif Sengun (Brown University, Rhode Island Hospital, Istanbul University), Brett Baggett (Brown University, Rhode Island Hospital), Nilufer Turan (Brown University, Rhode Island Hospital), Eric Mi (Brown University, Rhode Island Hospital), Bianca Kun (Brown University), John Sedivy (Brown University), Gideon Koren (Brown University, Rhode Island Hospital)
Presenting Author Brown University, Rhode Island Hospital, Istanbul University Providence, Rhode Island
Objectives: Cellular senescence is a stress response involving permanent replicative arrest. It is accompanied by a complex senescence-associated secretory phenotype (SASP), which is characterized by the presence of pro-inflammatory cytokines and chemokines, growth factors, and tissue-remodeling metalloproteinases. Little is known regarding the role of senescence and the SASP in the context of arrhythmias post myocardial infarction (MI). Here, we characterized the arrhythmogenic cardiac consequences and molecular mechanisms underlying tissue remodeling changes in impaired or accelerated cardiac myofibroblast (CMF) senescence and the pro-inflammatory SASP during post-MI wound healing process in genetically engineered mice.
Material-
Methods: Impaired or accelerated CMF-specific senescence was achieved by using cre-lox mouse models to delete p53 or MDM2 genes. MI surgery via direct ligation of the left anterior descending artery (LAD) was performed in 4-month-old wild-type (WT), Pstn-Cre(+/-) p53(fl/fl), Pstn-MerCreMer(+/-) MDM2(fl/fl), and respective littermate control (LMC) mice of both sexes. Changes in cardiac structure and function post-MI were assessed by echocardiography. Senescence-associated β-galactosidase (SA-βgal) staining was applied to detect and quantify senescent cells in three zones: infarct zone (IZ), infarct border zone (IBZ), and remote zone (RZ). Immunofluorescence staining identified the types of senescent cells. Masson’s trichrome staining was used for fibrosis assessment. RT-qPCR was performed to quantitate the expression of known senescence genes and canonical SASP factors.
Results: Pstn-Cre(+/-) p53(fl/fl) mice displayed significantly decreased CMF senescence two weeks post-MI in the scar compared to littermate control p53(fl/fl) and WT mice. We noticed a similar trend in the IBZ, but this did not reach statistical significance. Pstn-MCM(+/-) MDM2(fl/fl) mice showed significantly increased CMF senescence in the IZ compared littermate control MDM2(fl/fl) mice. We observed a similar trend in the IBZ, but this did not reach statistical significance. In all mice, we observed essentially no senescence in the RZ. Our data did not show any significant difference in fibrosis between any genotype in any zone. We did not observe any overall trend in differential expression in senescence and SASP genes between p53(fl/fl) and Pstn-Cre(+/-) p53(fl/fl) mice in any zone. There was no evidence of any sex-specific differences in aforementioned results.
Conclusions: A significant increase and persistence of CMF senescence likely contributes to pathological tissue remodeling during the post-MI wound healing process. This is likely due to SASP-induced pro-arrhythmogenic chronic inflammation or via direct cell-cell interactions between senescent CMFs and myocytes.
Support or Funding Information
This research is funded by NIH grants R01HL139467 and 1R1AG049608-01. E.S. is supported by TUBITAK (BIDEB 2214-A).